Is Painreform Stock a Good Investment?
Painreform Investment Advice | PRFX |
- Examine Painreform's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Painreform's leadership team and their track record. Good management can help Painreform navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Painreform's business and its evolving consumer preferences.
- Compare Painreform's performance and market position to its competitors. Analyze how Painreform is positioned in terms of product offerings, innovation, and market share.
- Check if Painreform pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Painreform's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Painreform stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Painreform is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Painreform Stock
Researching Painreform's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book ratio of 0.63. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Painreform recorded a loss per share of 147.36. The entity had not issued any dividends in recent years. The firm had 1:6 split on the 9th of September 2024.
To determine if Painreform is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Painreform's research are outlined below:
| Painreform had very high historical volatility over the last 90 days | |
| Net Loss for the year was (9.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Painreform currently holds about 13.85 M in cash with (6.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.3. | |
| Painreform has a poor financial position based on the latest SEC disclosures | |
| Latest headline from benzinga.com: US Stocks Mostly Lower Target Posts Downbeat Earnings |
Painreform Quarterly Cost Of Revenue |
|
Painreform uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Painreform. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Painreform's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Painreform's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Painreform's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-15 | 2022-09-30 | -0.17 | -0.1983 | -0.0283 | 16 | ||
2023-05-16 | 2023-03-31 | -0.32 | -0.22 | 0.1 | 31 | ||
2023-03-15 | 2022-12-31 | -0.15 | -0.3 | -0.15 | 100 | ||
2021-11-16 | 2021-09-30 | -0.43 | -0.18 | 0.25 | 58 | ||
2024-05-15 | 2024-03-31 | -2.4 | -2.72 | -0.32 | 13 | ||
2021-05-13 | 2021-03-31 | -0.56 | -0.23 | 0.33 | 58 | ||
2021-08-16 | 2021-06-30 | -0.51 | -0.16 | 0.35 | 68 | ||
2022-03-17 | 2021-12-31 | -0.55 | -0.17 | 0.38 | 69 |
Know Painreform's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Painreform is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Painreform backward and forwards among themselves. Painreform's institutional investor refers to the entity that pools money to purchase Painreform's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Virtu Financial Llc | 2024-06-30 | 20.1 K | Advisor Group Holdings, Inc. | 2024-06-30 | 4.6 K | Ubs Group Ag | 2024-06-30 | 432 | Armistice Capital, Llc | 2024-09-30 | 0.0 |
Painreform's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.68 M.Market Cap |
|
Painreform's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.94) | (0.99) | |
| Return On Capital Employed | (1.27) | (1.34) | |
| Return On Assets | (0.94) | (0.99) | |
| Return On Equity | (1.29) | (1.23) |
Determining Painreform's profitability involves analyzing its financial statements and using various financial metrics to determine if Painreform is a good buy. For example, gross profit margin measures Painreform's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Painreform's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Painreform's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Painreform. Check Painreform's Beneish M Score to see the likelihood of Painreform's management manipulating its earnings.
Evaluate Painreform's management efficiency
Painreform has return on total asset (ROA) of (1.9507) % which means that it has lost $1.9507 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.1667) %, meaning that it created substantial loss on money invested by shareholders. Painreform's management efficiency ratios could be used to measure how well Painreform manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.99 in 2024. Return On Capital Employed is likely to drop to -1.34 in 2024. At this time, Painreform's Net Tangible Assets are fairly stable compared to the past year. Total Assets is likely to rise to about 11.1 M in 2024, whereas Other Current Assets are likely to drop slightly above 1.3 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 33.21 | 34.87 | |
| Tangible Book Value Per Share | 33.21 | 34.87 | |
| Enterprise Value Over EBITDA | (0.67) | (0.71) | |
| Price Book Value Ratio | 1.99 | 2.09 | |
| Enterprise Value Multiple | (0.67) | (0.71) | |
| Price Fair Value | 1.99 | 2.09 | |
| Enterprise Value | 116.7 M | 110.9 M |
The strategic decisions made by Painreform management significantly impact its financial stability and market performance. Evaluating these factors helps determine whether the stock is a worthwhile investment.
Beta 0.555 |
Basic technical analysis of Painreform Stock
As of the 26th of November, Painreform holds the Risk Adjusted Performance of 0.0192, semi deviation of 10.74, and Coefficient Of Variation of 8019.51. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Painreform, as well as the relationship between them.Painreform's Outstanding Corporate Bonds
Painreform issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Painreform uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Painreform bonds can be classified according to their maturity, which is the date when Painreform has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Painreform's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Painreform's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0192 | |||
| Market Risk Adjusted Performance | (0.24) | |||
| Mean Deviation | 9.45 | |||
| Semi Deviation | 10.74 | |||
| Downside Deviation | 11.21 | |||
| Coefficient Of Variation | 8019.51 | |||
| Standard Deviation | 22.31 | |||
| Variance | 497.62 | |||
| Information Ratio | 0.0067 | |||
| Jensen Alpha | 0.3948 | |||
| Total Risk Alpha | (3.19) | |||
| Sortino Ratio | 0.0133 | |||
| Treynor Ratio | (0.25) | |||
| Maximum Drawdown | 187.4 | |||
| Value At Risk | (19.48) | |||
| Potential Upside | 13.13 | |||
| Downside Variance | 125.55 | |||
| Semi Variance | 115.36 | |||
| Expected Short fall | (11.82) | |||
| Skewness | 5.92 | |||
| Kurtosis | 43.3 |
| Risk Adjusted Performance | 0.0192 | |||
| Market Risk Adjusted Performance | (0.24) | |||
| Mean Deviation | 9.45 | |||
| Semi Deviation | 10.74 | |||
| Downside Deviation | 11.21 | |||
| Coefficient Of Variation | 8019.51 | |||
| Standard Deviation | 22.31 | |||
| Variance | 497.62 | |||
| Information Ratio | 0.0067 | |||
| Jensen Alpha | 0.3948 | |||
| Total Risk Alpha | (3.19) | |||
| Sortino Ratio | 0.0133 | |||
| Treynor Ratio | (0.25) | |||
| Maximum Drawdown | 187.4 | |||
| Value At Risk | (19.48) | |||
| Potential Upside | 13.13 | |||
| Downside Variance | 125.55 | |||
| Semi Variance | 115.36 | |||
| Expected Short fall | (11.82) | |||
| Skewness | 5.92 | |||
| Kurtosis | 43.3 |
Consider Painreform's intraday indicators
Painreform intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Painreform stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Painreform Corporate Filings
6K | 20th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 16th of October 2024 Other Reports | ViewVerify | |
| 20th of September 2024 Other Reports | ViewVerify |
Painreform Stock media impact
Far too much social signal, news, headlines, and media speculation about Painreform that are available to investors today. That information is available publicly through Painreform media outlets and privately through word of mouth or via Painreform internal channels. However, regardless of the origin, that massive amount of Painreform data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Painreform news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Painreform relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Painreform's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Painreform alpha.
Painreform Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Painreform can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Painreform Corporate Management
| Sigal Aviel | Chief Officer | Profile | |
| Rita Keynan | Vice Operations | Profile | |
| MBA MBA | CEO CFO | Profile | |
| Pr Hazum | CTO Director | Profile | |
| Stephen DMD | Executive Development | Profile |
Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.